
EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos

EuroPCR 2023: Defining the future

EuroPCR 2023: Vascular access

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Tricuspid valve

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

Navitor™: Voice of the Experts Mohammed Saad

AV Valves Summit 2024 | Opening of Day 2

Navitor™: Voice of the Experts Francesco Nicolas Dumonteil

TAVI Summit 2023: Streamline implantation

Trending Controversies | AV Valves

AV VALVES 2023: Morphology

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler